Bayer Agrees To Stop Running Ads For Oral Contraceptive YAZ That FDA Says Are 'Misleading' (Medical News Today)
Earlier this week, the pharmaceutical company Bayer agreed to stop airing commercials for the oral contraceptive YAZ in response to an Oct. 3 warning letter from FDA telling the company that the advertisements overstate the benefits of the drug.

FDA Clears Neurostar TMS Therapy For The Treatment Of Depression (Medical News Today)
Neuronetics, Inc., a privately-held medical device company and a leader in the field of neuromodulation, announced today that the U.S. Food and Drug Administration (FDA) has cleared its NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system for the treatment of depression.

FDA Statement Following CHPA's Announcement On Nonprescription Over-The-Counter Cough And Cold Medicines In Children (Medical News Today)
The U.S. Food and Drug Administration supports the voluntary actions by CHPA members to help prevent and reduce misuse and to better inform consumers about the safe and effective use of these products for children. The FDA continues to assess the safety and efficacy of these products and to revise its OTC monograph (list of approved ingredients and amounts) for these medicines.